Overview
ERDERA's 2026 call funds multinational early-phase rare-disease clinical trials. The mandatory Expression of Interest stage closes 10 September 2026.
Complete grant details
The European Rare Diseases Research Alliance has opened its Clinical Trial Call 2026 for multinational, GCP-compliant Phase I, Phase I/II and Phase II interventional clinical trials in rare diseases. The mandatory Stage 0 Expression of Interest runs from 1 July to 10 September 2026. Stage 1 short proposals are scheduled for 15 September to 29 October 2026, followed by a structured support phase and full proposals in 2027. ERDERA has dedicated up to €30 million to the call; individual project budgets are expected broadly in the €1 million to €5 million range where justified. Funding is centralised and administered by Fondazione Telethon on behalf of ERDERA.
Eligibility requirements
Eligible applicants include universities and research institutes, hospitals and clinical centres, non-profit research organisations and foundations, patient advocacy organisations, and SMEs subject to the call's funding rules. Funded partners are currently eligible from 27 listed countries including Lithuania, Ireland, Croatia, Slovenia and other European/Horizon Europe countries, plus Canada, Israel, Türkiye and the UK. The clinical trial sponsor must be established in an EU Member State or Norway. Applications must be multinational and satisfy the official clinical-trial, consortium and country-eligibility conditions.
Tips for this grant
Practical Job and Scholarship guidance. These tips do not replace official rules or create new eligibility requirements.
- Check eligibility, funding coverage, study/project level and every required document before investing time in the application.
- Prepare transcripts, references, language tests, proposal/motivation statement and proof documents early.
- Separate the scholarship deadline from any university/program admission deadline; they may be different.
- Treat “fully funded” as a source fact only when the official provider explicitly confirms the covered costs.
Verification notes
Verified against ERDERA's official Clinical Trial Call 2026 page, official call text and 1 July 2026 launch announcement. The mandatory EOI stage is open 1 July-10 September 2026; short proposals are planned 15 September-29 October 2026. ERDERA states that up to €30 million is dedicated to the call, individual project budgets are expected broadly in the €1 million-€5 million range, and the call uses a centralised funding model administered by Fondazione Telethon. No clock time is published for the EOI deadline on the official public page, so the machine deadline is left null rather than inventing one.
Job and Scholarship is the discovery and verification layer. Confirm eligibility, dates, salary/funding and application instructions on the original source before submitting anything.
ERDERA ↗